This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Beigene, Ltd.. Active years: 2022-2023.
Company Filing History:
Years Active: 2022-2023
Title: Desheng Yu: Innovator in Pharmaceutical Chemistry
Introduction
Desheng Yu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. With a total of 2 patents, his work focuses on improving treatments for various diseases.
Latest Patents
Desheng Yu's latest patents include groundbreaking inventions such as crystalline forms of (S)-7-(1-(but-2-ynoyl)piperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide. This invention relates to a crystalline form that inhibits Btk, along with methods of preparation and pharmaceutical compositions for treating diseases like allergies, autoimmune disorders, inflammatory diseases, and cancer. Another notable patent involves BTK inhibitors with improved dual selectivity, which provides a method and composition for inhibiting Btk and treating diseases associated with undesirable Btk activity.
Career Highlights
Desheng Yu is currently associated with BeiGene, Ltd., a leading biotechnology company focused on molecularly targeted and immuno-oncology drug discovery. His work at BeiGene has positioned him as a key player in the development of innovative therapies that address critical health challenges.
Collaborations
Desheng Yu collaborates with talented professionals in his field, including coworkers Yunhang Guo and Zhiwei Wang. Their combined expertise contributes to the advancement of pharmaceutical research and the development of effective treatments.
Conclusion
Desheng Yu's contributions to pharmaceutical chemistry and his innovative patents highlight his commitment to improving healthcare solutions. His work continues to pave the way for advancements in the treatment of various diseases.